Ethotoin

乙苯妥英

Report date: 2022/01/19 20:00:34
NME

Base Information

Drug NameEthotoin
Drug Alias Nameethotoinum乙基苯妥英乙苯妥因乙妥英乙妥因 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsSeizuresEpilepsy
Global Approved IndicationsSeizuresEpilepsy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1957/04/22
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesRecordati Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecordati Rare Diseases Inc
Active IndicationsN/A
Inactive IndicationsSeizuresEpilepsy

Other Information

ATC CodeN03AB01
Related LinksN/A